Presentation

Now PAT employs 40 people, half of whom are part of the Research department.

2005

PLANT ADVANCED TECHNOLOGIES PAT was founded in 2005 in Nancy taking advantage of a new technology, PAT plant milking®, originated from the University of Lorraine (INPL-INRA, Institut National Polytechnique de Lorraine). The three co-founders of the company are Jean-Paul Fèvre, President and CEO, Pr. Frédéric Bourgaud, Vice-President Research and Pr. Eric Gontier.

Newly created, PAT developped new proprietary technologies such as PAT Friday, an innovative platform for the production of recombinant proteins in the liquid of carnivorous plants.

2009

PAT is registered in the Paris NYSE Euronext’s equities market (ISIN FR0010785790). The firm raises 2 millions euros in 2 years. Currently Plant Advanced Technologies PAT has over 2,400 shareholders.

2010

PAT take over a company specialized in custom-made synthetic chemistry (Synthelor). This encourages a diversification of the competences in the enterprise as this chemistry is a complementary activity to produce and optimize active plant extracts.

2012

The first industrial production contract is completed for a worldwide cosmetic group for the supply of an innovative and polyactive anti-ageing Exudactive®.

2014

4 hectares of greenhouses are acquired in Lorraine (France) to meet the customers’ growing demands in innovative natural extracts. Thus, the research and production area grows, as well as R&D and production investments.

2015

The company is certified ISO90001-2008 (by LRQA) for its entire activity, a proof of quality that insure traceability and better organisation control.

2016

3 new active ingredients are launched in cosmetic including one with the Expanscience Laboratories. 

2017

PAT headquarters move up to their new own facilites still in Vandoeuvre-lès-Nancy-France.

Creation of Temisis subsidiary in December 2017 in Nancy (France), based on the discovery of original compounds with remarkable anti-inflammatory properties.

The company owns a diversified portfolio of tens of international patents and 9 trademarks.
Today, PAT employs 40 people, half of whom are part of the Research department.

Croissance externeDe récentes croissances externes ont permis à PAT SA de diversifier ses revenus et savoir-faire :

TEMISIS

December 2017

Temisis, a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing a strong inflammatory component.

Collaboration

StratiCell

IN VITRO SKIN MODELS AND TESTING COSMETICS   The Belgian company StratiCell, a 100% subsidiary of PAT Plant Advanced Technologies, is specialized in [...]
Collaboration

Couleurs de Plantes

A company at the heart and the service of the environment   Couleurs de Plantes® was established in early 2005 as a continuation [...]
Collaboration

PAT Zerbaz

a great variety of plants serving cosmetic and pharmaceutical industrie   Created in December 2015, PAT Zerbaz is a civil farming company and [...]
Collaboration

Newsletter

Inscrivez-vous à notre liste de diffusion et restez informé de toute l’actualité de PAT